These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 15821887

  • 1. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R, Yang Y, Mildvan D, Evans SR, Schnizlein-Bick CT, Hafner R, Webb N, Basar M, Zackin R, Jacobson MA.
    J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
    [Abstract] [Full Text] [Related]

  • 2. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S, Galán I, Bellón JM, Navarro ML, León JA, Muñoz-Fernandez MA.
    J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
    [Abstract] [Full Text] [Related]

  • 3. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR, Zaunders JJ, Cunningham P, Kelleher AD, Grey P, Smith D, Carr A, Cooper DA.
    AIDS; 2000 Dec 01; 14(17):2643-51. PubMed ID: 11125882
    [Abstract] [Full Text] [Related]

  • 4. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 5. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T, Qiu Z, Wang A, Sheng R.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1391-5. PubMed ID: 12509921
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2973-6. PubMed ID: 18261327
    [Abstract] [Full Text] [Related]

  • 7. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 8. Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment.
    Hua W, Jiao Y, Zhang H, Zhang T, Chen D, Zhang Y, Chen X, Wu H.
    Immunol Invest; 2012 Jan 15; 41(1):1-14. PubMed ID: 21563924
    [Abstract] [Full Text] [Related]

  • 9. CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.
    Lange CG, Valdez H, Medvik K, Asaad R, Lederman MM.
    Clin Immunol; 2002 Feb 15; 102(2):154-61. PubMed ID: 11846457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA.
    AIDS; 2008 Oct 01; 22(15):1937-41. PubMed ID: 18784457
    [Abstract] [Full Text] [Related]

  • 14. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
    Evans TG, Bonnez W, Soucier HR, Fitzgerald T, Gibbons DC, Reichman RC.
    Antiviral Res; 1998 Oct 01; 39(3):163-73. PubMed ID: 9833957
    [Abstract] [Full Text] [Related]

  • 15. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
    Wu H, Connick E, Kuritzkes DR, Landay A, Spritzler J, Zhang B, Spear GT, Kessler H, Lederman MM, ACTG 315 Team.
    AIDS Res Hum Retroviruses; 2001 Sep 01; 17(13):1231-40. PubMed ID: 11559422
    [Abstract] [Full Text] [Related]

  • 16. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    Gómez-Mora E, Massanella M, García E, Giles D, Bernadó M, Urrea V, Carrillo J, Ouchi D, Puig J, Negredo E, Clotet B, Blanco J, Cabrera C.
    PLoS One; 2017 Sep 01; 12(9):e0184433. PubMed ID: 28934217
    [Abstract] [Full Text] [Related]

  • 17. Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.
    Pallikkuth S, Fischl MA, Pahwa S.
    J Infect Dis; 2013 Nov 15; 208(10):1613-23. PubMed ID: 23922374
    [Abstract] [Full Text] [Related]

  • 18. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
    Lepej SZ, Begovac J, Vince A.
    FEMS Immunol Med Microbiol; 2006 Apr 15; 46(3):351-9. PubMed ID: 16553807
    [Abstract] [Full Text] [Related]

  • 19. Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens.
    Atzori C, Clerici M, Trabattoni D, Fantoni G, Valerio A, Tronconi E, Cargnel A.
    J Antimicrob Chemother; 2003 Aug 15; 52(2):276-81. PubMed ID: 12837736
    [Abstract] [Full Text] [Related]

  • 20. Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients.
    Tincati C, Bellistrì GM, Ancona G, Merlini E, d'Arminio Monforte A, Marchetti G.
    Clin Dev Immunol; 2012 Aug 15; 2012():935425. PubMed ID: 22400042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.